Lebedeva et al. (2014) found a negative correlation between cortical thickness and levels of CSF T-tau and P-tau in AD patients with depressive symptoms which were not observed for CSF Aβ42 and suggests that only tau pathology is linked to depressive symptoms in AD. The gene discussed is MAPT; the disease is Alzheimer disease.